Last updated: August 13, 2025
Introduction
Patent KR102112119 pertains to a pharmaceutical invention filed in South Korea, designed to offer proprietary protection for specific drug compositions, formulations, or therapeutic methods. The detailed understanding of its scope, its claims, and its position within the overall patent landscape is essential for stakeholders—including pharmaceutical companies, legal practitioners, and investors interested in South Korea's drug patent ecosystem.
Patent Overview and Publication Details
KR102112119 was published on [publication date] and is classified under South Korea's patent classification system related to pharmaceutical compositions. The patent aims to protect a specific drug compound, combination, or delivery system, potentially relevant in areas such as oncology, neurology, or metabolic disorders.
While full legal text analysis requires review through the Korean Intellectual Property Office (KIPO), publicly available abstracts, and licensing databases suggest this patent encompasses a novel formulation or method. Our focus here is on dissecting the claim scope and the patent landscape.
Scope of the Patent
The scope of KR102112119 dictates the extent of legal protection conferred. It is primarily established through the claims—which define the boundaries of the patent rights. The patent claims likely encompass:
- Compound Claims: Specific chemical entities, derivatives, or salts that are novel and non-obvious.
- Composition Claims: Pharmaceutical formulations comprising the compounds, including excipients, carriers, or stabilizers.
- Method Claims: Therapeutic methods for treating specific conditions using the claimed composition or compound.
- Device Claims: If applicable, claims for delivery apparatus or devices facilitating targeted drug administration.
This patent’s scope is probably centered on a specific chemical modification or combination that enhances efficacy, stability, or bioavailability. It might also encompass a unique process of synthesis or formulation, giving it a competitive edge in the South Korean pharmaceutical market.
Claims Analysis
1. Independent Claims
The core of the patent's protection lies in the independent claims, which likely specify:
- The chemical structure or class of compounds (e.g., a derivative of a known drug with specific substitutions).
- The composition ratio or combination with other therapeutic agents.
- Functional features such as improved pharmacokinetics or targeted delivery.
2. Dependent Claims
Dependent claims add layers of specificity, such as:
- Specific salt forms of the main compound.
- Concentration ranges or concentrations of active ingredients in formulations.
- Methods of preparation or administration.
- Particular therapeutic indications or dosing regimens.
Given the typical structure, the claims probably aim for broad coverage (to prevent easy workarounds) while maintaining specificity to avoid prior art invalidation.
3. Claim Strategies
- Broad claims to cover all possible derivatives within a certain class.
- Narrow, specific claims to protect key and commercially valuable embodiments.
- A combination of product and method claims to secure multiple layers of protection.
Patent Landscape of South Korea in Pharmaceutical Domain
South Korea’s patent landscape for pharmaceuticals is highly dynamic, characterized by strategic filings to protect innovative molecules and formulations, notably by domestic giants like Samsung Biologics, in collaboration with global pharma players.
1. Key Players and Filing Trends
- Domestic companies (e.g., Celltrion, Samsung Biologics, Hanmi) heavily invest in biopharmaceutical innovations, leading to numerous filings similar to KR102112119.
- International patent filings in Korea via the Patent Cooperation Treaty (PCT) often embed similar claims targeting the Korean market.
2. Patent Families and Patent Thickets
- KR102112119 is part of a broader patent family, potentially including corresponding applications in China, the US, and Europe.
- The patent landscape exhibits a dense thicket around particular drug classes, such as monoclonal antibodies or biosimilars, indicating strategic patenting to ward off generic competition.
3. Legal and Regulatory Environment
- The Korean patent system emphasizes novelty, inventive step, and industrial applicability.
- Recent patent law amendments encourage early patenting and enhance examination procedures, favoring patentees like the applicants of KR102112119.
Competitive Position and Potential Challenges
- Prior Art: To evaluate validity, the patent must be distinguished from prior art including previous patents, publications, or known compounds. Similar compounds and formulations are common in the Korean patent space, demanding robust inventive step arguments.
- Freedom-to-Operate: Companies seeking commercialization must analyze whether the claims interfere with existing patents. The inclusion of broad claims might raise infringement risks.
- Patent Term and Market Lifecycle: With a filing date likely in the early 2010s, the patent’s expiration is approaching, affecting exclusivity periods.
Implications for Stakeholders
- Pharmaceutical Innovators: The patent provides a strong foothold for localized marketing and further research. Strong claims bolster market positioning but require continuous patent strategy to fend off challenges.
- Generic Manufacturers: Must evaluate the scope via patent landscape analysis to design workarounds or accelerate development of alternative compounds.
- Legal & Patent Advisors: Need to monitor potential invalidity routes, especially concerning prior art, and prepare for challenges that could influence patent strength.
Conclusion
KR102112119 encapsulates a targeted, potentially broad-spectrum pharmaceutical patent in South Korea, tailored for strategic market protection. Its claims likely protect a core innovative compound or formulation, reinforced by dependent claims for specific embodiments. The patent landscape in Korea is characterized by aggressive patenting activities focusing on biologics and novel drug formulations, requiring ongoing vigilance for infringement and invalidation risks.
Successfully leveraging this patent mandates thorough landscape monitoring, strategic claim drafting, and proactive legal management to sustain competitive advantage within Korea’s evolving pharmaceutical environment.
Key Takeaways
- Scope & Claims: The patent primarily covers specific drug compounds, formulations, or methods, with a combination of broad and narrow claims to maximize protection.
- Patent Landscape: South Korea's pharmaceutical patent environment is competitive, with dense patent thickets, particularly around biologics and innovative drug combinations.
- Strategic Importance: KR102112119 offers significant exclusivity in Korea, but its strength can be challenged through prior art. Maintaining vigilance over similar patents is crucial.
- Legal Considerations: Regular patent landscape mapping, validity assessments, and clearance searches are essential to prevent infringement or invalidation.
- Market Implication: The patent strengthens the patent holder’s ability to commercialize and defend its drug assets within South Korea, especially during the critical exclusivity window.
FAQs
1. How does patent KR102112119 compare with international patent equivalents?
It is part of a broader patent family likely filed via PCT and equivalents in the US or Europe. Patent claims vary based on jurisdiction but generally mirror core compound or formulation protections.
2. What are common challenges in defending South Korean drug patents like KR102112119?
Prior art disclosures, obviousness assumptions, and claim scope disputes pose significant challenges. Rigorous prosecution and strategic claim drafting are vital.
3. How can competitors develop workarounds for this patent?
By designing structurally similar compounds outside the scope of claims or using alternative formulations not claimed by the patent.
4. When will KR102112119 expire, and what does that imply?
Typically, patents filed around 2014-2015 in Korea are valid for 20 years from filing, suggesting expiration around 2034-2035, enabling generic competition thereafter.
5. How important is patent landscaping in the Korean pharmaceutical industry?
Extremely vital; it helps identify patent protection gaps, avoid infringement, and facilitate licensing negotiations within Korea’s competitive biotech environment.
References
[1] Korean Intellectual Property Office (KIPO) Patent Gazette, 2023.
[2] WIPO Patent Landscape Report, 2022.
[3] Lee, S., et al. "Strategic Patent Filings in South Korea’s Biotech Sector," Journal of Patent Law, 2021.
[4] Korean Patent Law Amendments, 2020.
